Inventor · disambiguated record
Tina Albertson
Also filed as: ALBERTSON TINA
7 granted patents·9 pending applications·22 citations·filing 2013–2023
80Inventor score
Top patents by PatentIndex Score
16 records- 0192US11944647B2Articles of manufacture and methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·5 cites·20 claims
- 0292US11413310B2Articles of manufacture and methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2018·Granted Aug 16, 2022·12 cites·55 claims
- 0380US11564946B2Methods associated with tumor burden for assessing response to a cell therapyJUNO THERAPEUTICS INC·Filed 2018·Granted Jan 31, 2023·2 cites·40 claims
- 0478US11366118B2Detection and treatment of CD30+ cancersSEATTLE GENETICS INC·Filed 2019·Granted Jun 21, 2022·1 cites·13 claims
- 0578US2024115612A1Articles of manufacture and methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0676US12168027B2Methods associated with tumor burden for assessing response to a cell therapyJUNO THERAPEUTICS INC·Filed 2022·Granted Dec 17, 2024·0 cites·37 claims
- 0775US2024151713A1Articles of manufacture and methods related to toxicity associated with cell therapyJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0869US10444241B2Detection and treatment of CD30+ cancersSEATTLE GENETICS INC·Filed 2013·Granted Oct 15, 2019·2 cites·9 claims
- 0962US11740231B2Articles of manufacture and methods related to toxicity associated with cell therapyJUNO THERAPEUTICS INC·Filed 2018·Granted Aug 29, 2023·0 cites·33 claims
- 1049US2022031746A1Methods for dosing and treatment of b cell malignancies in adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1146US2022088070A1Methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1245US2022008465A1Methods of dosing engineered t cells for the treatment of b cell malignanciesJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1344US2021198372A1Methods for dosing and for modulation of genetically engineered cellsJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1438US2020078400A1Methods for determining car-t cells dosingJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1538US2019358262A1Methods for modulation of car-t cellsJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1631US2017182178A1Optimal dosing of a cd19-antibody drug conjugateSEATTLE GENETICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tina Albertson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →